Guardian Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$474K Hold
3,750
0.31% 46
2026
Q1
$523K Hold
3,750
0.41% 44
2025
Q4
$460K Hold
3,750
0.36% 46
2025
Q3
$416K Hold
3,750
0.35% 50
2025
Q2
$416K Hold
3,750
0.42% 45
2025
Q1
$420K Sell
3,750
-1,000
-21% -$103K 0.35% 47
2024
Q4
$439K Sell
4,750
-900
-16% -$81K 0.31% 52
2024
Q3
$474K Hold
5,650
0.41% 53
2024
Q2
$432K Sell
5,650
-250
-4% -$16.7K 0.31% 54
2024
Q1
$432K Hold
5,900
0.35% 53
2023
Q4
$478K Sell
5,900
-1,650
-22% -$128K 0.4% 51
2023
Q3
$547K Hold
7,550
0.5% 45
2023
Q2
$582K Sell
7,550
-5,950
-44% -$475K 0.5% 49
2023
Q1
$873K Buy
13,500
+5,700
+73% +$472K 0.65% 44
2022
Q4
$670K Sell
7,800
-2,800
-26% -$222K 0.63% 41
2022
Q3
$653K Sell
10,600
-1,300
-11% -$82K 0.66% 39
2022
Q2
$673K Hold
11,900
0.59% 46
2022
Q1
$707K Sell
11,900
-300
-2% -$19.2K 0.55% 48
2021
Q4
$885K Hold
12,200
0.62% 42
2021
Q3
$852K Sell
12,200
-500
-4% -$35.1K 0.63% 43
2021
Q2
$875K Sell
12,700
-800
-6% -$53.4K 0.6% 45
2021
Q1
$875K Sell
13,500
-500
-4% -$32.2K 0.62% 44
2020
Q4
$816K Buy
+14,000
New +$845K 0.62% 43

Other funds holding GILD

Guardian Investment Management's GILD Position: Q2 2026 in Review

Guardian Investment Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,750 shares worth $474K. The position accounts for 0.31% of the portfolio, ranked #46.

Guardian Investment Management first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $885K in Q4 2021. 856 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Guardian Investment Management held 3,750 shares of Gilead Sciences worth $474K as of Q2 2026.
  • Guardian Investment Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.31% of Guardian Investment Management's portfolio in Q2 2026, its #46 holding.
  • Guardian Investment Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Guardian Investment Management's Gilead Sciences position peaked at $885K in Q4 2021.
  • 856 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Guardian Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.